CYTK : Summary for Cytokinetics, Incorporated - Yahoo Finance

U.S. Markets close in 4 hrs 40 mins

Cytokinetics, Incorporated (CYTK)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.98+0.08 (+0.44%)
As of 11:20AM EDT. Market open.
People also watch
CORTGTXIARRYCRISCYCC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close16.90
Open16.95
Bid16.90 x 400
Ask16.95 x 500
Day's Range16.45 - 17.20
52 Week Range7.18 - 17.20
Volume272,671
Avg. Volume538,996
Market Cap734.02M
Beta2.04
PE Ratio (TTM)43.53
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to Cytokinetics, Inc. : April 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytokinetics, Inc. Here are 5 ETFs with the largest exposure to CYTK-US. Comparing the performance and risk of Cytokinetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • GlobeNewswire6 days ago

    Cytokinetics Added to S&P SmallCap 600

    SOUTH SAN FRANCISCO, Calif., April 21, 2017-- Cytokinetics today announced it has been selected for addition to the S&P SmallCap 600 GICS Biotechnology Sub-Industry Index. The index, a member of the Dow ...

  • Capital Cube7 days ago

    Cytokinetics, Inc. – Value Analysis (NASDAQ:CYTK) : April 20, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Cytokinetics, Inc. a score of 93. Our analysis is based on comparing Cytokinetics, Inc. with the following peers – ARCA biopharma, Inc., Ligand Pharmaceuticals Incorporated, GTx, Inc., Trevena, Inc., Acorda Therapeutics, Inc., Amgen Inc., ArQule, Inc., Eiger BioPharmaceuticals, Inc. and Array BioPharma Inc. (ABIO-US, LGND-US, GTXI-US, TRVN-US, ... Read more (Read more...)